ceptional multivitamin supplementation on congenital abnormalities other than neural tube defects, which is the subject of this paper.
Abstract
Objective-:-To study the effect of periconceptional multivitamin supplementation on neural tube defects and other congenital abnormality entities.
Design-Randomised controlled trial of supplementation with multivitamins and trace elements.
Setting-Hungarian family planning programme. Subjects-4156 pregnancies with known outcome and 3713 infants evaluated in the eighth month of life.
Interventions-A single tablet of a multivitamin including 0.8 mg of folic acid or trace elements supplement daily for at least one month before conception and at least two months after conception.
Main outcome measures-Number of major and mild congenital abnormalities.
Results-The rate of all major congenital abnormalities was significantly lower in the group given vitamins than in the group given trace elements and this difference cannot be explained totally by the significant reduction of neural tube defects. The rate of major congenital abnormalities other than neural tube defects and genetic syndromes was 9.0/1000 in pJ'egnancies with known outcome in the vitamin group and 16.6/1000 in the trace element group; relative risk 1.85 (95% confidence interval 1.02 to 3.38); difference, 7.6/1000. The rate of all major congenital abnormalities other than neural tube defects and genetic syndromes diagnosed up to the eighth month of life was 14.7/1000 informative pregnancies in the vitamin group and 28.3/1000 in the trace element group; relative risk 1.95 (1.23 to 3-09) ; difference, 13.6/1000. The rate of some congenital abnormalities was lower in the vitamin group than in the trace element group but the differences for each group of abnormalities were not significant.
Conclusions-Periconceptional multivitamin supplementation can reduce not only the rate of neural tube defects but also the rate of other major non-genetic syndromatic congenital abnormalities. Further studies are needed to differentiate the chance effect and vitamin dependent effect.
Methods
The Hungarian randomised controlled trial of periconceptional multivitamin supplementation was part of the Hungarian family planning programme, which was established on 1 February 1984. Couples who satisfy three criteria are eligible for participation in this programme: no delayed conception or infertility (that is, inability to conceive after more than 12 months of sexual activity without contraception); not currently pregnant; voluntary participation. In the first four years of the programme, there were two other criteria: age of the woman under 35 (older women were referred to the genetic counselling clinic) and no previous wanted pregnancy (induced abortion was not a reason for exclusion). The programme involves three main steps performed or supervised by qualified nurses: a check of reproductive health'; a three month preparation for conception including multivitamin or trace element supplementation; and protection of early pregnancy . 8 At the first visit eligible couples were informed about the purpose of multivitamin use and about the "blind" use of one of two kinds of tablets-that is, they were asked whether they agreed to be allocated to either group on the basis of a randomisation table. After this, the women were asked to sign a written informed consent and to stop taking other vitamins. The participants were advised to take a single tablet of either the "vitamin,"
Elevit Pronatal (Roche), composed of 12 vitamins (vitamin A 6000 IV till the end of 1989 and 4000 IU in 1990-1, E-l 1.6 mg, E-2 1.8 mg, nicotinamide 19.0 mg, E-6 2.6 mg, calcium pantothenate 10 mg, biotin 0.2 mg, E-12 4.0 IJ.g, C 100 mg, D 500 IV, E 15 mg, folic acid 0.8 mg), four minerals (calcium 125 mg, phosphorous 125 mg, magnesium 100 mg, iron 60 mg), and three trace elements (copper 1 mg, manganese 1 mg, zinc 7.5 mg) or the "trace element" supplement (copper 1 mg, manganese 1 mg, zinc 7.5 mg, and vitamin C 7.5 mg) each day for one month before planned conception.
At the second visit women were supplied with tablets for a further three months and were asked to attempt to conceive and to visit us again immediately after the first missed menstrual period. If the participant did not conceive within three months she was supplied with tablets for the next three months, a month at a time. The purpose of the third visit was the confirmation of pregnancy by a sensitive serum pregnancy test after the first missed menstrual period. Pregnancy was also confirmed by ultrasonography within two weeks. Further tablets were supplied until the 12th week of gestation. The fourth visit was a farewell meeting at the 12th week of pregnancy because after this the pregnant women were referred to other clinics for routine antenatal care. The compliance with the regimen of supplementation was verified verbally in discussion with the women; by evaluating the check marks on the form for the basal body
Introduction
Periconceptional supplementation with a multivitamin including folic acid t , or with folic acid alone' .. can reduce the recurrence of neural tube defects. The Hungarian randomised controlled trial showed that the occurrence of neural tube defects could be appreciably reduced by giving periconceptional multivitamin supplements (including 0.8 mg of folic acid).' This primary preventive method has great public health significance, being a better alternative than prenatal diagnosis and selective abortion. In addition to the lessening of human suffering, supplementation would decrease medical costs. The expected extensive use of periconceptional multivitamin and folic acid supplementation demands studies on the effects of this preventive method on pregnancy outcomes and maternal health.' The Hungarian randomised controlled trial was appropriate to study the effect of pericon- detailed physician's description (discharge summary, a written report from the examining physician, etc), and necropsy records. The data concerning congenital abnormalities were evaluated by an independent data monitoring group every six months.
Infants were given a physical examination during the eighth month of life after a mail or telephone invitation to attend the family planning centre. After review of medical documents concerning previously diagnosed congenital abnormalities and diseases, treatments, operations, the examination included a paediatric evaluation performed "blind" by two paediatricians. If families did not take part in these examinations, they were invited again to participate. If there was still no response we contacted the infant's paediatrician and the medical history, particularly data concerning congenital abnormalities, diagnosed after birth, were obtained.
Two-tailed X2 and Fisher exact tests were used for statistical evaluation. temperature measurement; and by counting unused tablets when boxes were returned. The criteria for full, partial, and no supplementation have been presented elsewhere. ' After the end of the pregnancy we were sent the completed certificate for each of the participants which included the date of pregnancy outcome and any congenital abnormalities of prenatally diagnosed and stillborn fetuses or liveborn infants. The certificate was filled in by the mothers and confirmed by their physician. In Hungary all deliveries and terminations of pregnancies take place in obstetrical inpatient clinics. Considerable effort was undertaken to assure that pregnancy outcomes of all women with a confirmed pregnancy were evaluated. If the completed certificate was not received one month after the expected date of delivery, a letter was mailed to the women asking her to send the completed certificate or discharge summary, or both. If there was no response a member of staff visited her at home. Only after such efforts failed were the participants considered to have dropped out from the study.
Pregnancies with known outcomes. (prenatally diagnosed and affected fetuses of pregnancies tern1inated in the second trimester; stillborn fetuses and liveborn infants known to have, or be free of, congenital abnormalities) were evaluated with particular attention to the occurrence and correct diagnosis or description of congenital abnormalities. After the report of a case as having congenital abnormality, as much clinical and pathological information as possible was obtained, 1646
Results
The code was broken at the end of 1991. Of 4753 participants with confirmed pregnancies, pregnancy outcomes were ascertained in 4704 cases (drop out 1%). The numbers of women given full, partially, and no supplements (1699+471+224 v 1682+451+177) were not significantly different between vitamin and trace element groups. Demographic factors were similar in the two groups (table I). Congenital abnormalities were divided into three groups: lethal and severe (which together constitUte major abnormalities) and mild.. Minor anomalies were excluded from this analysis. Table n shows the distribution of cases with major congenital abnormalities. There were six cases of neural tUbe defects in the group receiving the trace element supplement compared with none in the vitamin group.' Isolated hydrocephalus did not occur in the vitamin group but two cases with congenital hydrocephalus were found in the trace element group. Some experts (for example, Lorber,'o have suggested that some cases of isolated hydrocephalus may properly be regarded as part of the neural tUbe defect spectrum. Four newborn infants with cleft lip with or without cleft palate were found in the vitamin group and three in the trace element group. (One case in the Some other congenital abnormality entities had a lower rate in the vitamin group than in the trace element group but the difference was not significant for individual abnormalities. However, a general trend is worth mentioning. The intention to treat analysis (when fully, partially, and unsupplemented cases were evaluated together in the vitamin or trace element groups) showed that the total rate of cases with major congenital abnormalities in informative pregnancies whose outcome was known was significantly higher in the trace element group than in the vitamin group (21.0/1000 v 10.9/1000; X~=6.68, p=0.01), When neural tube defects were excluded the difference was not significant (X~=3.68; p=0.055). It seemed reasonable to exclude genetic syndromes (Down, Alagille, collodion baby) as well, and then, the number of cases was 19 (9.0/1000) in the vitamin group and 34 (16'6/ 1000) in the trace element group; the difference was significant (X~=4,69; p=0.03) and the relative risk was 1.85 (95% confidence interval 1.02 to 3.38). Multiple abnormalities (tWo or more different abnormalities in the same fetus or infant'2) were found in 10 cases that could not be classified as having congenital abnormality syndrome.
The number of major congenital abnormalities in infants evaluated d!lring the eighth month of life was significantly higher in the trace element group than in the vitamin group (X~=4.30; p=0.038).
The total rate of all major congenital abnormalities diagnosed from the second trimester of gestation until the eighth month of life was significantly different betWeen the vitamin and trace element groups (X~ = 11.13; p=0.0008). After cases with neural tube defects and genetic syndromes were excluded there were 31 cases in the vitamin group and 58 in the trace element group, rates of 14-7 and 28-3, respectively, per 1000 pregnancies of known outcome-The difference was highly significant (X~=9-08; p=0-0025) and the relative risk was 1-95 (1-23 to 3-09)-
The differences in the congenital abnormality rates between the vitamin and trace element groups were explained for the most part by congenital limb deficiencies (1 in the vitamin group v 5 in the trace element group; p=0-124, Fisher's exact test), defects of the urinary system-that is, renal agenesis and obstructive defects (1 v 5; p=0-124), congenital hypertrophic pyloric stenosis (1 v 4; p=0-21), and cardiovascular malformations (10 v 17; p=0-16) (table ill)-The difference was close to significance in ventricular septal defect (8 v 2; p=0-06), but the diagnosis was based only on clinical findings in eight cases-Until the eighth month of life only one infant in the trace element group had surgery, and ventricular septal defect was found at necropsy of a fetus with a birth weight of 770 gin the vitamin groupThe number of cases with mild congenital abnormalities was not significantly different between the vitamin and trace element groups in pregnancies with a known outcome (X~=0-38; p=0-54) and in infants assessed during the eighth month of life (X~=0-05; p= 0-82) (table IV)-Some mild congenital abnormalities were present in surprisingly high numbers (for example, defonnities of feet), but the predetermined diagnostic criteria for mild congenital abnormalities (for example, surgery to correct congenital inguinal hernia; Pavlik pillow for at least three months in congenital dislocation of the hip; orthopaedic treatment, mainly plaster casts, in deformities of feet; undescended testis after the third month of life) were followed at the eight month examinationAll congenital dislocations of the hip were diagnosed through neonatal orthopaedic screening; thus these cases had only an Ortolanj click-that is, a predisposition to this congenital abnormality-The difference effect and effect of vitamins in the origin of these congenital abnonnalities and to clarify the mechanism of this primary preventive method.
betWeen the groups ran in the opposite direction to most other congenital abnormalitit:s and was not significant (X~= 1.99; p=O.157). 
Discussion
Congenital abnormalities diagnosed from the second trimester of pregnancy until the age of 1 year are expected to occur in 65/lOO births in Hungary." The observed rate of congenital abnormalities (67/1000) was close to this figure in the trace element group.
The observed rate of cases with major congenital abnormalities other than neural tube defects and genetic syndromes diagnosed prenatally or immediately after birth was significantly lower in the group given vitamins than in the group given trace elements, The difference between these two groups, 7.6 per 1000 in pregnancies whose outcome was known, is 2.7 times higher than the prevalence of neural tube defects at birth (2-8/1000) in Hungary."The rate ofall cases with major congenital abnormalities diagnosed till the eighth month of life, other than genetic syndromes and neural tube defects, was also significantly lower in the vitamin group than in the trace element group. The difference between two groups, 13.6 per 1000, is more than 4'9 times the rate of neural tube defects. Thus, periconceptional supplementation with multivitamins including folic acid seems to prevent congenital abnormalities.
The incidence of mild congenital abnormalities was not significantly different between the vitamin and trace element groups. The high rate of congenital dislocation of the hip in Hungary is well known.'4" VITAMINS AND AETIOLOGY OF CONGENITAL ABNORMALI-TIES Congenital abnormality entities have specific genetic or environmental teratogenic aetiologies, or both; thuĩ t is difficult to suppose that periconceptional multivitamin supplementation could reduce the occurrence of more than one congenital abnormality entity (that is, neural tube defect). However, some biological compounds (such as antioxidants and aspirin) are known to have different effects, and vitamins may have a similar role. Folates are essential as coenzymes for the synthesis of both purines and pyrimidines; they are involved in nucleic acid synthesis and are therefore essential to all cell division.".
Cell division is exceptionally rapid at critical stages of specific developmental fields in fetuses. Deficiency of folic acid was shown to be a risk factor for multiple defects,'7 cardiovascular malformations,181. and congenital abnormalities of the urinary system"' in experimental studies. The teratogenic effect of folic acid deficiency due to folic acid antagonists such as aminopterin and methotrexate caused, among other defects, limb deficiency in human embryos." " Folic acid may not be the only active compound preventing the diverse congenital abnormalities reported here. Folic acid, vitamin B-6, vitamin B-12, vitamin C, and zinc interact with one another in many metabolic pathways. In addition, vitamin dependencies rather than vitamin deficiencies may have some causal role in the origin of neural tube defects" and some other congenital abnormalities.
Periconceptional multivitamin supplementation can reduce the occurrence of neural tube defects and the results of this study also indicate a significant decrease in the rate of other major congenital abnormalities. Further studies are needed to differentiate the chance
